
|Videos|July 15, 2022
CAR T-cell therapy in prostate cancer: Early results and ongoing trials
Author(s)Urology Times staff
Advertisement
Tanya Dorff, MD, discusses early results with CAR T-cell therapy in patients with prostate cancer and describes ongoing clinical trials exploring the treatment in this setting. Dorff is a medical oncologist, section chief of Genitourinary Disease Program, and associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA updates in urology: May 2026
4
FDA approves cefepime and zidebactam for complicated UTI
5











